<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="81706">
  <stage>Registered</stage>
  <submitdate>22/11/2006</submitdate>
  <approvaldate>28/05/2007</approvaldate>
  <actrnumber>ACTRN12607000280404</actrnumber>
  <trial_identification>
    <studytitle>A single-centre, randomized comparsion of the Efficacy and Safety of Intramuscular Olanzapine and Haloperidol in Treating Acutely Agitated patients in Emergency Department</studytitle>
    <scientifictitle>A single-centre, randomized comparsion of the Efficacy and Safety of Intramuscular Olanzapine and Haloperidol in Treating Acutely Agitated patients in Emergency Department</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Sedation for the acutely agitated patients</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2 />
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients are randomized to either olanzapine or haloperidol groups. The study aim is to compare the time for sedation of acutely agitated patients in the olanzapine group (new treatment) with haloperidol group (traditional treatment). The duration of intervention is about 30 minutes after single dose of study drug. The dose of olanzapine and haloperidol are both intramuscularly 10mg.  The estimated study period will be approximately one year and the sample size is approx 140 in each study group i.e. 280 subjects in total.</interventions>
    <comparator>Haloperidol group (traditional treatment). </comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Time to sedation</outcome>
      <timepoint>Measured from the time of administration of the study drug till the sedation scale (modified Thomas Combativeness scale)  to 3 i.e. no agitation and  no supervision required and time</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Time to arousal defined as if the patient awakens to verbal commands, is able to count backwards from 10 to 1 and is able to follow simple commands</outcome>
      <timepoint>Measured from the time of administration of the study drugs</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Any adverse events of drugs, that occurs during the intervention/study period.</outcome>
      <timepoint>Within 30 minutes.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Acute agitation that required chemical restraint.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Readily reversible aetiology for the agitationhypotensionknown allergy to either drugvisible or suspected head traumaunable to maintain their own airwayin respiratory distressknown pregnancyknown Parkinson's disease or Lewy Body Dementiaaged </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>sealed opaque envelopes</concealment>
    <sequence>permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Subjects and therapist are blinded</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/08/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>280</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Peninsula Health (Emergency Department)</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Peninsula Health</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>No secondary sponsor</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine IM olanzapine is more effectivd than haloperidol in treating acutely agitated patients in the emergency department setting</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname> Peninsula Health</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Barry Chan</name>
      <address>Frankston Hospital
Hastings Road
Frankston VIC 3199</address>
      <phone>+61 3 97847777</phone>
      <fax>+61 3 97847284</fax>
      <email>bchan@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Barry Chan</name>
      <address>Frankston Hospital
Hastings Road
Frankston VIC 3199</address>
      <phone>+61 3 97847777</phone>
      <fax>+61 3 97847284</fax>
      <email>bchan@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>